New diabetes pill shows promise in early trial
NCT ID NCT00707954
First seen Jan 08, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study tested an experimental diabetes drug, TA-7284, in 61 adults with type 2 diabetes. Participants took the pill once daily for 15 days to check safety and how it affects blood sugar and insulin. The goal was to find the right dose for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
P-One Clinic
Hachiōji, Tokyo-to, Japan
Conditions
Explore the condition pages connected to this study.